# [Corrigendum] Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy

**Authors:** Xiu-Wu Pan, Lin Li, Yi Huang, Hai Huang, Dan-Feng Xu, Yi Gao, Lu Chen, Ji-Zhong Ren, Jian-Wei Cao, Yi Hong, Xin-Gang Cui

PMC · DOI: 10.3892/or.2026.9056 · 2026-01-21

## Full-text entities

- **Genes:** MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, GABARAPL1 (GABA type A receptor associated protein like 1) [NCBI Gene 23710] {aka APG8-LIKE, APG8L, ATG8, ATG8B, ATG8L, GEC1}, ATG12 (autophagy related 12) [NCBI Gene 9140] {aka APG12, APG12L, FBR93, HAPG12}, ATG7 (autophagy related 7) [NCBI Gene 10533] {aka APG7-LIKE, APG7L, GSA7, SCAR31}, ATG3 (autophagy related 3) [NCBI Gene 64422] {aka APG3, APG3-LIKE, APG3L, PC3-96, hApg3}
- **Diseases:** bladder cancer (MESH:D001749)
- **Chemicals:** epirubicin (MESH:D015251), Icaritin (MESH:C499403)
- **Cell lines:** BT5637 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_0126), T24 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_0554)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12853148/full.md

---
Source: https://tomesphere.com/paper/PMC12853148